Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840–846 - DOI:10.1159/000453608 © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840–846 - DOI:10.1159/000453608 © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0
Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840–846 - DOI:10.1159/000453608 © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0